Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

A retrospective review for the use of palliative sedation in a regional hospital in Hong Kong.

Tin WW, Lo SH, Wong FC.

Ann Palliat Med. 2019 Sep 26. pii: apm.2019.09.05. doi: 10.21037/apm.2019.09.05. [Epub ahead of print]

2.

Association Between Oxygen Saturation Targeting and Death or Disability in Extremely Preterm Infants in the Neonatal Oxygenation Prospective Meta-analysis Collaboration.

Askie LM, Darlow BA, Finer N, Schmidt B, Stenson B, Tarnow-Mordi W, Davis PG, Carlo WA, Brocklehurst P, Davies LC, Das A, Rich W, Gantz MG, Roberts RS, Whyte RK, Costantini L, Poets C, Asztalos E, Battin M, Halliday HL, Marlow N, Tin W, King A, Juszczak E, Morley CJ, Doyle LW, Gebski V, Hunter KE, Simes RJ; Neonatal Oxygenation Prospective Meta-analysis (NeOProM) Collaboration.

JAMA. 2018 Jun 5;319(21):2190-2201. doi: 10.1001/jama.2018.5725. Erratum in: JAMA. 2018 Jul 17;320(3):308.

3.

Neurobehavioral Outcomes 11 Years After Neonatal Caffeine Therapy for Apnea of Prematurity.

Mürner-Lavanchy IM, Doyle LW, Schmidt B, Roberts RS, Asztalos EV, Costantini L, Davis PG, Dewey D, D'Ilario J, Grunau RE, Moddemann D, Nelson H, Ohlsson A, Solimano A, Tin W, Anderson PJ; Caffeine for Apnea of Prematurity (CAP) Trial Group.

Pediatrics. 2018 May;141(5). pii: e20174047. doi: 10.1542/peds.2017-4047. Epub 2018 Apr 11.

4.

Academic Performance, Motor Function, and Behavior 11 Years After Neonatal Caffeine Citrate Therapy for Apnea of Prematurity: An 11-Year Follow-up of the CAP Randomized Clinical Trial.

Schmidt B, Roberts RS, Anderson PJ, Asztalos EV, Costantini L, Davis PG, Dewey D, D'Ilario J, Doyle LW, Grunau RE, Moddemann D, Nelson H, Ohlsson A, Solimano A, Tin W; Caffeine for Apnea of Prematurity (CAP) Trial Group.

JAMA Pediatr. 2017 Jun 1;171(6):564-572. doi: 10.1001/jamapediatrics.2017.0238.

PMID:
28437520
5.

Monitoring and comparing the perinatal outcomes of very preterm infants: the challenges ahead.

Tin W.

Arch Dis Child Fetal Neonatal Ed. 2016 Sep;101(5):F374-5. doi: 10.1136/archdischild-2015-310130. Epub 2016 Jun 10. No abstract available.

PMID:
27288394
6.

Outcomes of Two Trials of Oxygen-Saturation Targets in Preterm Infants.

BOOST-II Australia and United Kingdom Collaborative Groups, Tarnow-Mordi W, Stenson B, Kirby A, Juszczak E, Donoghoe M, Deshpande S, Morley C, King A, Doyle LW, Fleck BW, Davis PG, Halliday HL, Hague W, Cairns P, Darlow BA, Fielder AR, Gebski V, Marlow N, Simmer K, Tin W, Ghadge A, Williams C, Keech A, Wardle SP, Kecskes Z, Kluckow M, Gole G, Evans N, Malcolm G, Luig M, Wright I, Stack J, Tan K, Pritchard M, Gray PH, Morris S, Headley B, Dargaville P, Simes RJ, Brocklehurst P.

N Engl J Med. 2016 Feb 25;374(8):749-60. doi: 10.1056/NEJMoa1514212. Epub 2016 Feb 10.

7.

Automated control of inspired oxygen in ventilated preterm infants: crossover physiological study.

Lal M, Tin W, Sinha S.

Acta Paediatr. 2015 Nov;104(11):1084-9. doi: 10.1111/apa.13137.

PMID:
26194933
8.

Editorial.

Donn SM, Tin W.

Semin Fetal Neonatal Med. 2015 Jun;20(3):129. doi: 10.1016/j.siny.2015.03.010. Epub 2015 Apr 16. No abstract available.

PMID:
25892176
9.

Predicting severe motor impairment in preterm children at age 5 years.

Synnes A, Anderson PJ, Grunau RE, Dewey D, Moddemann D, Tin W, Davis PG, Doyle LW, Foster G, Khairy M, Nwaesei C, Schmidt B; CAP Trial Investigator group.

Arch Dis Child. 2015 Aug;100(8):748-53. doi: 10.1136/archdischild-2014-307695. Epub 2015 Mar 17.

PMID:
25784749
10.

Principles of pulse oximetry and its clinical application in neonatal medicine.

Tin W, Lal M.

Semin Fetal Neonatal Med. 2015 Jun;20(3):192-7. doi: 10.1016/j.siny.2015.01.006. Epub 2015 Feb 18. Review.

PMID:
25704605
11.

Adjunctive drug therapies for treatment of respiratory diseases in the newborn: based on evidence or habit?

Sinha S, Tin W.

Ther Adv Respir Dis. 2014 Apr;8(2):53-62. doi: 10.1177/1753465814526444. Review.

PMID:
24670391
12.

Defining neonatal hypoglycaemia: a continuing debate.

Tin W.

Semin Fetal Neonatal Med. 2014 Feb;19(1):27-32. doi: 10.1016/j.siny.2013.09.003. Epub 2013 Oct 19. Review.

PMID:
24148999
13.

Oxygen saturation and outcomes in preterm infants.

BOOST II United Kingdom Collaborative Group; BOOST II Australia Collaborative Group; BOOST II New Zealand Collaborative Group, Stenson BJ, Tarnow-Mordi WO, Darlow BA, Simes J, Juszczak E, Askie L, Battin M, Bowler U, Broadbent R, Cairns P, Davis PG, Deshpande S, Donoghoe M, Doyle L, Fleck BW, Ghadge A, Hague W, Halliday HL, Hewson M, King A, Kirby A, Marlow N, Meyer M, Morley C, Simmer K, Tin W, Wardle SP, Brocklehurst P.

N Engl J Med. 2013 May 30;368(22):2094-104. doi: 10.1056/NEJMoa1302298. Epub 2013 May 5.

14.

15-year follow-up of recurrent "hypoglycemia" in preterm infants.

Tin W, Brunskill G, Kelly T, Fritz S.

Pediatrics. 2012 Dec;130(6):e1497-503. doi: 10.1542/peds.2012-0776. Epub 2012 Nov 5.

PMID:
23129080
15.

Survival without disability to age 5 years after neonatal caffeine therapy for apnea of prematurity.

Schmidt B, Anderson PJ, Doyle LW, Dewey D, Grunau RE, Asztalos EV, Davis PG, Tin W, Moddemann D, Solimano A, Ohlsson A, Barrington KJ, Roberts RS; Caffeine for Apnea of Prematurity (CAP) Trial Investigators.

JAMA. 2012 Jan 18;307(3):275-82. doi: 10.1001/jama.2011.2024.

PMID:
22253394
16.

Caffeine for Apnea of Prematurity trial: benefits may vary in subgroups.

Davis PG, Schmidt B, Roberts RS, Doyle LW, Asztalos E, Haslam R, Sinha S, Tin W; Caffeine for Apnea of Prematurity Trial Group.

J Pediatr. 2010 Mar;156(3):382-7. doi: 10.1016/j.jpeds.2009.09.069. Epub 2009 Nov 18.

PMID:
19926098
17.

Drug therapies in bronchopulmonary dysplasia: debunking the myths.

Tin W, Wiswell TE.

Semin Fetal Neonatal Med. 2009 Dec;14(6):383-90. doi: 10.1016/j.siny.2009.08.003. Epub 2009 Sep 10. Review.

PMID:
19747890
18.
19.

Long-term effects of caffeine therapy for apnea of prematurity.

Schmidt B, Roberts RS, Davis P, Doyle LW, Barrington KJ, Ohlsson A, Solimano A, Tin W; Caffeine for Apnea of Prematurity Trial Group.

N Engl J Med. 2007 Nov 8;357(19):1893-902.

20.

Adjunctive therapies in chronic lung disease: examining the evidence.

Tin W, Wiswell TE.

Semin Fetal Neonatal Med. 2008 Feb;13(1):44-52. Epub 2007 Nov 5. Review.

PMID:
17983879
21.

Evidence-based use of adjunctive therapies to ventilation.

Wiswell TE, Tin W, Ohler K.

Clin Perinatol. 2007 Mar;34(1):191-204, ix. Review.

PMID:
17394938
22.

Optimum oxygen therapy in preterm babies.

Tin W, Gupta S.

Arch Dis Child Fetal Neonatal Ed. 2007 Mar;92(2):F143-7. Review.

23.

Caffeine therapy for apnea of prematurity.

Schmidt B, Roberts RS, Davis P, Doyle LW, Barrington KJ, Ohlsson A, Solimano A, Tin W; Caffeine for Apnea of Prematurity Trial Group.

N Engl J Med. 2006 May 18;354(20):2112-21.

24.

Optimal oxygen saturation for preterm babies. Do we really know?

Tin W.

Biol Neonate. 2004;85(4):319-25. Epub 2004 Jun 8. Review.

PMID:
15218290
25.

Oxygen therapy during neonatal resuscitation--too little or too much?

Sinha S, Tin W.

Indian Pediatr. 2003 Jun;40(6):507-9. No abstract available.

26.

The controversies surrounding oxygen therapy in neonatal intensive care units.

Sinha SK, Tin W.

Curr Opin Pediatr. 2003 Apr;15(2):161-5. Review.

PMID:
12640272
27.

Oxygen monitoring in preterm babies: too high, too low?

Tin W, Walker S, Lacamp C.

Paediatr Respir Rev. 2003 Mar;4(1):9-14. Review.

PMID:
12615027
28.

Giving small babies oxygen: 50 years of uncertainty.

Tin W, Wariyar U.

Semin Neonatol. 2002 Oct;7(5):361-7. Review.

PMID:
12464498
29.

Oxygen therapy: 50 years of uncertainty.

Tin W.

Pediatrics. 2002 Sep;110(3):615-6. No abstract available.

PMID:
12205267
30.

Pulse oximetry, severe retinopathy, and outcome at one year in babies of less than 28 weeks gestation.

Tin W, Milligan DW, Pennefather P, Hey E.

Arch Dis Child Fetal Neonatal Ed. 2001 Mar;84(2):F106-10.

31.

Ocular abnormalities associated with cerebral palsy after preterm birth.

Pennefather PM, Tin W.

Eye (Lond). 2000 Feb;14 ( Pt 1):78-81.

PMID:
10755106
32.

Six years' experience of prophylactic oral vitamin K.

Wariyar U, Hilton S, Pagan J, Tin W, Hey E.

Arch Dis Child Fetal Neonatal Ed. 2000 Jan;82(1):F64-8.

33.

Bias due to incomplete follow up in a cohort study.

Pennefather PM, Tin W, Clarke MP, Dutton J, Fritz S, Hey EN.

Br J Ophthalmol. 1999 Jun;83(6):643-5.

34.

Risk factors for strabismus in children born before 32 weeks' gestation.

Pennefather PM, Clarke MP, Strong NP, Cottrell DG, Dutton J, Tin W.

Br J Ophthalmol. 1999 May;83(5):514-8.

35.

Outcome of very preterm birth: children reviewed with ease at 2 years differ from those followed up with difficulty.

Tin W, Fritz S, Wariyar U, Hey E.

Arch Dis Child Fetal Neonatal Ed. 1998 Sep;79(2):F83-7.

36.

A comparison of two methods of follow-up in a trial of prophylactic volume expansion in preterm babies.

Fooks J, Fritz S, Tin W, Yudkin P, Johnson A, Elbourne D, Hey E.

Paediatr Perinat Epidemiol. 1998 Apr;12(2):199-216.

PMID:
9620569
37.

Preventing late bleeding in infants with vitamin K deficiency.

Tin W, Wariyar U, Hey E.

BMJ. 1998 Jan 17;316(7126):230. No abstract available.

38.

Gestational assessment assessed.

Wariyar U, Tin W, Hey E.

Arch Dis Child Fetal Neonatal Ed. 1997 Nov;77(3):F216-20.

39.
41.

Refractive errors in children born before 32 weeks gestation.

Pennefather PM, Tin W, Strong NP, Clarke MP, Dutton J, Cottrell DG.

Eye (Lond). 1997;11 ( Pt 5):736-43.

PMID:
9474329
42.

Retinopathy of prematurity in a controlled trial of prophylactic surfactant treatment.

Pennefather PM, Tin W, Clarke MP, Fritz S, Strong NP.

Br J Ophthalmol. 1996 May;80(5):420-4.

43.

Ocular outcome in children born before 32 weeks gestation.

Pennefather PM, Clarke MP, Strong NP, Cottrell DG, Fritz S, Tin W.

Eye (Lond). 1995;9 ( Pt 6 Su):26-30.

PMID:
8729015

Supplemental Content

Support Center